Skip to main content

Meet UltraShape® Power. The non-thermal ultrasound system for body contouring.

UltraShape® Power is FDA-cleared for non-invasive reduction in abdominal circumference and fat reduction in the abdomen, flanks, and thighs.1,2 

It gently destroys fat by delivering non-thermal ultrasound energy waves that are:

  • Focused - delivering ultrasound energy to tissue within a precise focal volume at a controlled depth1 
  • Pulsed - the mechanical non-thermal effect results in minimal elevation of 0.8°C in treated tissue2 for a truly comfortable and gentle treatment experience3-5 
  • Selective - precisely targeting fat cells while blood vessels, nerves, and surrounding tissue remain largely unaffected

Four huge selling points for potential body contouring patients.

  1. Selective. Since UltraShape Power selectively and precisely targets fat cells, blood vessels, nerves, and surrounding tissue are largely unharmed.1 There are no reported cases of lumping, shelving, or other contouring deformities. Immediate responses recorded in a clinical study were mild and transient in nature, and completely resolved without intervention within days.3,4 
  2. It’s a walk-in, walk-out procedure that’s virtually painless. In a recent clinical study, the average reported pain level was <1 on a 10-point scale.3-5
  3. The UltraShape Power pulsed ultrasound treatment is truly comfortable. In fact, in the same study, 96% of patients said they felt comfortable during treatment.3,5
  4. It gets real results — fast. The entire process is just three sessions, spaced two weeks apart.3 The average treatment only takes about 30 minutes per area.5 The fat destruction results are impressive. As in, an average abdominal circumference reduction of 2.4 to 2.6 cm.3,7

Five ways UltraShape Power can help your practice grow.

  1. Faster treatments. UltraShape Power’s optional Fly Mode minimizes treatment time, shortening sessions.
  2. Superior profitability. With UltraShape Power, profit per patient is higher than other non-invasive fat destruction methods, leading to significantly higher yearly net profits.
  3. Quicker return on investment. UltraShape Power offers a competitive treatment cost compared to other non-invasive fat destruction methods. For example, consumables costs are typically 35 - 50% lower for coverage of full abdomen.8
  4. Expanded consumer base. UltraShape Power’s efficacy extends to patients with BMI >28. Which means you can now offer liposuction candidates a non-invasive alternative.
  5. Business development support. Candela can help extend your practice’s reach with consumer marketing toolkits and assistance in bringing in patients to your practice.
Get a feature-rich body contouring system that’s ideal for your practice.
Body contouring is trending. Capitalize on this major market opportunity.

Ready to destroy fat and build your practice?

Let a Candela product expert show you how UltraShape Power can help deliver great results for you and your patients.


Product Specifications

Dimensions  110 x 38 x 45 cm / 43 x 15 x 18 in (HxWxD)
System Weight  45 kg / 99 lb
Acoustic Pressure Up to 12 g, 660 W/cm2
Frequency ~200 kHz
Video Camera HD digital
Screen 15” - capacitive


  1. Brown SA, Greenbaum L, Shtukmaster S, Zadok Y, Ben-Ezra S, Kushkuley L. Characterization of nonthermal focused ultrasound for noninvasive selective fat cell disruption (lysis): technical and preclinical assessment. Plast Reconstr Surg. 2009;124(1):92-101. 
  2. Syneron Candela, data on file. 
  3. UltraShape Power 510(k) clearance for abdomen (K160896), July 2016. 
  4. UltraShape Power 510(k) clearance for flanks and thighs (K170370), May 2017. 
  5. Amir R. A single-center, controlled study to assess the effectiveness and safety of the UltraShape Power® System using U-Sculpt Power transducer for abdominal non-invasive fat reduction. Clinical Report, FDA, March 2016. Syneron Candela, data on file.
  6. Teitelbaum SA, Burns JL, Kubota J, et al. Noninvasive body contouring by focused ultrasound: safety and efficacy of the Contour I device in a multicenter, controlled, clinical study. Plast Reconstr Surg. 2007;120(3):779-789.
  7. Multicenter study data. Syneron Candela, data on file.  
  8. Data on file: Syneron–Candela ROI comparison.
  9. Professional, non-invasive, energy-based. Source: Medical Insight Inc., 2015.
  10. Syneron proprietary consumer survey 2012 and 2015.
  11. Base: Total (n=1000), Ages of 25 – 60, Leger Marketing, Company controlled sponsored market research.